Global Biodefense Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Biodefense market size is predicted to grow from US$ 1287 million in 2025 to US$ 1994 million in 2031; it is expected to grow at a CAGR of 7.6% from 2025 to 2031.
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian Market is the main application, which holds a share about 55%.
LPI (LP Information)' newest research report, the “Biodefense Industry Forecast” looks at past sales and reviews total world Biodefense sales in 2024, providing a comprehensive analysis by region and market sector of projected Biodefense sales for 2025 through 2031. With Biodefense sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biodefense industry.
This Insight Report provides a comprehensive analysis of the global Biodefense landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biodefense portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biodefense market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biodefense and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biodefense.
This report presents a comprehensive overview, market shares, and growth opportunities of Biodefense market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Biodefense market size is predicted to grow from US$ 1287 million in 2025 to US$ 1994 million in 2031; it is expected to grow at a CAGR of 7.6% from 2025 to 2031.
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian Market is the main application, which holds a share about 55%.
LPI (LP Information)' newest research report, the “Biodefense Industry Forecast” looks at past sales and reviews total world Biodefense sales in 2024, providing a comprehensive analysis by region and market sector of projected Biodefense sales for 2025 through 2031. With Biodefense sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biodefense industry.
This Insight Report provides a comprehensive analysis of the global Biodefense landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biodefense portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biodefense market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biodefense and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biodefense.
This report presents a comprehensive overview, market shares, and growth opportunities of Biodefense market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- Others
- US Military Market
- US Civilian Market
- Non - US Market
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Emergent Biosolutions
- Hytest
- GSK
- Sanofi
- PharmAthene
- Bavarian Nordic
- SIGA Technologies
- Arbutus Biopharma
- DynPort Vaccine
- Xoma Corporation
- Ichor Medical Systems
- Aeolus Pharmaceuticals
- Achaogen
- Elusys Therapeutics
- Dynavax Technologies
- Cleveland BioLabs
- Soligenix
- Alnylam Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biodefense Market Size (2020-2031)
2.1.2 Biodefense Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Biodefense by Country/Region (2020, 2024 & 2031)
2.2 Biodefense Segment by Type
2.2.1 Anthrax
2.2.2 Smallpox
2.2.3 Botulism
2.2.4 Radiation/Nuclear
2.2.5 Others
2.3 Biodefense Market Size by Type
2.3.1 Biodefense Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Biodefense Market Size Market Share by Type (2020-2025)
2.4 Biodefense Segment by Application
2.4.1 US Military Market
2.4.2 US Civilian Market
2.4.3 Non - US Market
2.5 Biodefense Market Size by Application
2.5.1 Biodefense Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Biodefense Market Size Market Share by Application (2020-2025)
3 BIODEFENSE MARKET SIZE BY PLAYER
3.1 Biodefense Market Size Market Share by Player
3.1.1 Global Biodefense Revenue by Player (2020-2025)
3.1.2 Global Biodefense Revenue Market Share by Player (2020-2025)
3.2 Global Biodefense Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIODEFENSE BY REGION
4.1 Biodefense Market Size by Region (2020-2025)
4.2 Global Biodefense Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biodefense Market Size Growth (2020-2025)
4.4 APAC Biodefense Market Size Growth (2020-2025)
4.5 Europe Biodefense Market Size Growth (2020-2025)
4.6 Middle East & Africa Biodefense Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Biodefense Market Size by Country (2020-2025)
5.2 Americas Biodefense Market Size by Type (2020-2025)
5.3 Americas Biodefense Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biodefense Market Size by Region (2020-2025)
6.2 APAC Biodefense Market Size by Type (2020-2025)
6.3 APAC Biodefense Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biodefense Market Size by Country (2020-2025)
7.2 Europe Biodefense Market Size by Type (2020-2025)
7.3 Europe Biodefense Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biodefense by Region (2020-2025)
8.2 Middle East & Africa Biodefense Market Size by Type (2020-2025)
8.3 Middle East & Africa Biodefense Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIODEFENSE MARKET FORECAST
10.1 Global Biodefense Forecast by Region (2026-2031)
10.1.1 Global Biodefense Forecast by Region (2026-2031)
10.1.2 Americas Biodefense Forecast
10.1.3 APAC Biodefense Forecast
10.1.4 Europe Biodefense Forecast
10.1.5 Middle East & Africa Biodefense Forecast
10.2 Americas Biodefense Forecast by Country (2026-2031)
10.2.1 United States Market Biodefense Forecast
10.2.2 Canada Market Biodefense Forecast
10.2.3 Mexico Market Biodefense Forecast
10.2.4 Brazil Market Biodefense Forecast
10.3 APAC Biodefense Forecast by Region (2026-2031)
10.3.1 China Biodefense Market Forecast
10.3.2 Japan Market Biodefense Forecast
10.3.3 Korea Market Biodefense Forecast
10.3.4 Southeast Asia Market Biodefense Forecast
10.3.5 India Market Biodefense Forecast
10.3.6 Australia Market Biodefense Forecast
10.4 Europe Biodefense Forecast by Country (2026-2031)
10.4.1 Germany Market Biodefense Forecast
10.4.2 France Market Biodefense Forecast
10.4.3 UK Market Biodefense Forecast
10.4.4 Italy Market Biodefense Forecast
10.4.5 Russia Market Biodefense Forecast
10.5 Middle East & Africa Biodefense Forecast by Region (2026-2031)
10.5.1 Egypt Market Biodefense Forecast
10.5.2 South Africa Market Biodefense Forecast
10.5.3 Israel Market Biodefense Forecast
10.5.4 Turkey Market Biodefense Forecast
10.6 Global Biodefense Forecast by Type (2026-2031)
10.7 Global Biodefense Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Biodefense Forecast
11 KEY PLAYERS ANALYSIS
11.1 Emergent Biosolutions
11.1.1 Emergent Biosolutions Company Information
11.1.2 Emergent Biosolutions Biodefense Product Offered
11.1.3 Emergent Biosolutions Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Emergent Biosolutions Main Business Overview
11.1.5 Emergent Biosolutions Latest Developments
11.2 Hytest
11.2.1 Hytest Company Information
11.2.2 Hytest Biodefense Product Offered
11.2.3 Hytest Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Hytest Main Business Overview
11.2.5 Hytest Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Biodefense Product Offered
11.3.3 GSK Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Biodefense Product Offered
11.4.3 Sanofi Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 PharmAthene
11.5.1 PharmAthene Company Information
11.5.2 PharmAthene Biodefense Product Offered
11.5.3 PharmAthene Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 PharmAthene Main Business Overview
11.5.5 PharmAthene Latest Developments
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Information
11.6.2 Bavarian Nordic Biodefense Product Offered
11.6.3 Bavarian Nordic Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Bavarian Nordic Main Business Overview
11.6.5 Bavarian Nordic Latest Developments
11.7 SIGA Technologies
11.7.1 SIGA Technologies Company Information
11.7.2 SIGA Technologies Biodefense Product Offered
11.7.3 SIGA Technologies Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 SIGA Technologies Main Business Overview
11.7.5 SIGA Technologies Latest Developments
11.8 Arbutus Biopharma
11.8.1 Arbutus Biopharma Company Information
11.8.2 Arbutus Biopharma Biodefense Product Offered
11.8.3 Arbutus Biopharma Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Arbutus Biopharma Main Business Overview
11.8.5 Arbutus Biopharma Latest Developments
11.9 DynPort Vaccine
11.9.1 DynPort Vaccine Company Information
11.9.2 DynPort Vaccine Biodefense Product Offered
11.9.3 DynPort Vaccine Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 DynPort Vaccine Main Business Overview
11.9.5 DynPort Vaccine Latest Developments
11.10 Xoma Corporation
11.10.1 Xoma Corporation Company Information
11.10.2 Xoma Corporation Biodefense Product Offered
11.10.3 Xoma Corporation Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Xoma Corporation Main Business Overview
11.10.5 Xoma Corporation Latest Developments
11.11 Ichor Medical Systems
11.11.1 Ichor Medical Systems Company Information
11.11.2 Ichor Medical Systems Biodefense Product Offered
11.11.3 Ichor Medical Systems Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Ichor Medical Systems Main Business Overview
11.11.5 Ichor Medical Systems Latest Developments
11.12 Aeolus Pharmaceuticals
11.12.1 Aeolus Pharmaceuticals Company Information
11.12.2 Aeolus Pharmaceuticals Biodefense Product Offered
11.12.3 Aeolus Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Aeolus Pharmaceuticals Main Business Overview
11.12.5 Aeolus Pharmaceuticals Latest Developments
11.13 Achaogen
11.13.1 Achaogen Company Information
11.13.2 Achaogen Biodefense Product Offered
11.13.3 Achaogen Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Achaogen Main Business Overview
11.13.5 Achaogen Latest Developments
11.14 Elusys Therapeutics
11.14.1 Elusys Therapeutics Company Information
11.14.2 Elusys Therapeutics Biodefense Product Offered
11.14.3 Elusys Therapeutics Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Elusys Therapeutics Main Business Overview
11.14.5 Elusys Therapeutics Latest Developments
11.15 Dynavax Technologies
11.15.1 Dynavax Technologies Company Information
11.15.2 Dynavax Technologies Biodefense Product Offered
11.15.3 Dynavax Technologies Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Dynavax Technologies Main Business Overview
11.15.5 Dynavax Technologies Latest Developments
11.16 Cleveland BioLabs
11.16.1 Cleveland BioLabs Company Information
11.16.2 Cleveland BioLabs Biodefense Product Offered
11.16.3 Cleveland BioLabs Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Cleveland BioLabs Main Business Overview
11.16.5 Cleveland BioLabs Latest Developments
11.17 Soligenix
11.17.1 Soligenix Company Information
11.17.2 Soligenix Biodefense Product Offered
11.17.3 Soligenix Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Soligenix Main Business Overview
11.17.5 Soligenix Latest Developments
11.18 Alnylam Pharmaceuticals
11.18.1 Alnylam Pharmaceuticals Company Information
11.18.2 Alnylam Pharmaceuticals Biodefense Product Offered
11.18.3 Alnylam Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Alnylam Pharmaceuticals Main Business Overview
11.18.5 Alnylam Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biodefense Market Size (2020-2031)
2.1.2 Biodefense Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Biodefense by Country/Region (2020, 2024 & 2031)
2.2 Biodefense Segment by Type
2.2.1 Anthrax
2.2.2 Smallpox
2.2.3 Botulism
2.2.4 Radiation/Nuclear
2.2.5 Others
2.3 Biodefense Market Size by Type
2.3.1 Biodefense Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Biodefense Market Size Market Share by Type (2020-2025)
2.4 Biodefense Segment by Application
2.4.1 US Military Market
2.4.2 US Civilian Market
2.4.3 Non - US Market
2.5 Biodefense Market Size by Application
2.5.1 Biodefense Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Biodefense Market Size Market Share by Application (2020-2025)
3 BIODEFENSE MARKET SIZE BY PLAYER
3.1 Biodefense Market Size Market Share by Player
3.1.1 Global Biodefense Revenue by Player (2020-2025)
3.1.2 Global Biodefense Revenue Market Share by Player (2020-2025)
3.2 Global Biodefense Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIODEFENSE BY REGION
4.1 Biodefense Market Size by Region (2020-2025)
4.2 Global Biodefense Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biodefense Market Size Growth (2020-2025)
4.4 APAC Biodefense Market Size Growth (2020-2025)
4.5 Europe Biodefense Market Size Growth (2020-2025)
4.6 Middle East & Africa Biodefense Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Biodefense Market Size by Country (2020-2025)
5.2 Americas Biodefense Market Size by Type (2020-2025)
5.3 Americas Biodefense Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biodefense Market Size by Region (2020-2025)
6.2 APAC Biodefense Market Size by Type (2020-2025)
6.3 APAC Biodefense Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biodefense Market Size by Country (2020-2025)
7.2 Europe Biodefense Market Size by Type (2020-2025)
7.3 Europe Biodefense Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biodefense by Region (2020-2025)
8.2 Middle East & Africa Biodefense Market Size by Type (2020-2025)
8.3 Middle East & Africa Biodefense Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIODEFENSE MARKET FORECAST
10.1 Global Biodefense Forecast by Region (2026-2031)
10.1.1 Global Biodefense Forecast by Region (2026-2031)
10.1.2 Americas Biodefense Forecast
10.1.3 APAC Biodefense Forecast
10.1.4 Europe Biodefense Forecast
10.1.5 Middle East & Africa Biodefense Forecast
10.2 Americas Biodefense Forecast by Country (2026-2031)
10.2.1 United States Market Biodefense Forecast
10.2.2 Canada Market Biodefense Forecast
10.2.3 Mexico Market Biodefense Forecast
10.2.4 Brazil Market Biodefense Forecast
10.3 APAC Biodefense Forecast by Region (2026-2031)
10.3.1 China Biodefense Market Forecast
10.3.2 Japan Market Biodefense Forecast
10.3.3 Korea Market Biodefense Forecast
10.3.4 Southeast Asia Market Biodefense Forecast
10.3.5 India Market Biodefense Forecast
10.3.6 Australia Market Biodefense Forecast
10.4 Europe Biodefense Forecast by Country (2026-2031)
10.4.1 Germany Market Biodefense Forecast
10.4.2 France Market Biodefense Forecast
10.4.3 UK Market Biodefense Forecast
10.4.4 Italy Market Biodefense Forecast
10.4.5 Russia Market Biodefense Forecast
10.5 Middle East & Africa Biodefense Forecast by Region (2026-2031)
10.5.1 Egypt Market Biodefense Forecast
10.5.2 South Africa Market Biodefense Forecast
10.5.3 Israel Market Biodefense Forecast
10.5.4 Turkey Market Biodefense Forecast
10.6 Global Biodefense Forecast by Type (2026-2031)
10.7 Global Biodefense Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Biodefense Forecast
11 KEY PLAYERS ANALYSIS
11.1 Emergent Biosolutions
11.1.1 Emergent Biosolutions Company Information
11.1.2 Emergent Biosolutions Biodefense Product Offered
11.1.3 Emergent Biosolutions Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Emergent Biosolutions Main Business Overview
11.1.5 Emergent Biosolutions Latest Developments
11.2 Hytest
11.2.1 Hytest Company Information
11.2.2 Hytest Biodefense Product Offered
11.2.3 Hytest Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Hytest Main Business Overview
11.2.5 Hytest Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Biodefense Product Offered
11.3.3 GSK Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Biodefense Product Offered
11.4.3 Sanofi Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 PharmAthene
11.5.1 PharmAthene Company Information
11.5.2 PharmAthene Biodefense Product Offered
11.5.3 PharmAthene Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 PharmAthene Main Business Overview
11.5.5 PharmAthene Latest Developments
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Information
11.6.2 Bavarian Nordic Biodefense Product Offered
11.6.3 Bavarian Nordic Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Bavarian Nordic Main Business Overview
11.6.5 Bavarian Nordic Latest Developments
11.7 SIGA Technologies
11.7.1 SIGA Technologies Company Information
11.7.2 SIGA Technologies Biodefense Product Offered
11.7.3 SIGA Technologies Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 SIGA Technologies Main Business Overview
11.7.5 SIGA Technologies Latest Developments
11.8 Arbutus Biopharma
11.8.1 Arbutus Biopharma Company Information
11.8.2 Arbutus Biopharma Biodefense Product Offered
11.8.3 Arbutus Biopharma Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Arbutus Biopharma Main Business Overview
11.8.5 Arbutus Biopharma Latest Developments
11.9 DynPort Vaccine
11.9.1 DynPort Vaccine Company Information
11.9.2 DynPort Vaccine Biodefense Product Offered
11.9.3 DynPort Vaccine Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 DynPort Vaccine Main Business Overview
11.9.5 DynPort Vaccine Latest Developments
11.10 Xoma Corporation
11.10.1 Xoma Corporation Company Information
11.10.2 Xoma Corporation Biodefense Product Offered
11.10.3 Xoma Corporation Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Xoma Corporation Main Business Overview
11.10.5 Xoma Corporation Latest Developments
11.11 Ichor Medical Systems
11.11.1 Ichor Medical Systems Company Information
11.11.2 Ichor Medical Systems Biodefense Product Offered
11.11.3 Ichor Medical Systems Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Ichor Medical Systems Main Business Overview
11.11.5 Ichor Medical Systems Latest Developments
11.12 Aeolus Pharmaceuticals
11.12.1 Aeolus Pharmaceuticals Company Information
11.12.2 Aeolus Pharmaceuticals Biodefense Product Offered
11.12.3 Aeolus Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Aeolus Pharmaceuticals Main Business Overview
11.12.5 Aeolus Pharmaceuticals Latest Developments
11.13 Achaogen
11.13.1 Achaogen Company Information
11.13.2 Achaogen Biodefense Product Offered
11.13.3 Achaogen Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Achaogen Main Business Overview
11.13.5 Achaogen Latest Developments
11.14 Elusys Therapeutics
11.14.1 Elusys Therapeutics Company Information
11.14.2 Elusys Therapeutics Biodefense Product Offered
11.14.3 Elusys Therapeutics Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Elusys Therapeutics Main Business Overview
11.14.5 Elusys Therapeutics Latest Developments
11.15 Dynavax Technologies
11.15.1 Dynavax Technologies Company Information
11.15.2 Dynavax Technologies Biodefense Product Offered
11.15.3 Dynavax Technologies Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Dynavax Technologies Main Business Overview
11.15.5 Dynavax Technologies Latest Developments
11.16 Cleveland BioLabs
11.16.1 Cleveland BioLabs Company Information
11.16.2 Cleveland BioLabs Biodefense Product Offered
11.16.3 Cleveland BioLabs Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Cleveland BioLabs Main Business Overview
11.16.5 Cleveland BioLabs Latest Developments
11.17 Soligenix
11.17.1 Soligenix Company Information
11.17.2 Soligenix Biodefense Product Offered
11.17.3 Soligenix Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Soligenix Main Business Overview
11.17.5 Soligenix Latest Developments
11.18 Alnylam Pharmaceuticals
11.18.1 Alnylam Pharmaceuticals Company Information
11.18.2 Alnylam Pharmaceuticals Biodefense Product Offered
11.18.3 Alnylam Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Alnylam Pharmaceuticals Main Business Overview
11.18.5 Alnylam Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biodefense Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Biodefense Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Anthrax
Table 4. Major Players of Smallpox
Table 5. Major Players of Botulism
Table 6. Major Players of Radiation/Nuclear
Table 7. Major Players of Others
Table 8. Biodefense Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Biodefense Market Size byType (2020-2025) & ($ millions)
Table 10. Global Biodefense Market Size Market Share byType (2020-2025)
Table 11. Biodefense Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Biodefense Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Biodefense Market Size Market Share by Application (2020-2025)
Table 14. Global Biodefense Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Biodefense Revenue Market Share by Player (2020-2025)
Table 16. Biodefense Key Players Head office and Products Offered
Table 17. Biodefense Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Biodefense Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Biodefense Market Size Market Share by Region (2020-2025)
Table 22. Global Biodefense Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Biodefense Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Biodefense Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Biodefense Market Size Market Share by Country (2020-2025)
Table 26. Americas Biodefense Market Size byType (2020-2025) & ($ millions)
Table 27. Americas Biodefense Market Size Market Share byType (2020-2025)
Table 28. Americas Biodefense Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Biodefense Market Size Market Share by Application (2020-2025)
Table 30. APAC Biodefense Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Biodefense Market Size Market Share by Region (2020-2025)
Table 32. APAC Biodefense Market Size byType (2020-2025) & ($ millions)
Table 33. APAC Biodefense Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Biodefense Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Biodefense Market Size Market Share by Country (2020-2025)
Table 36. Europe Biodefense Market Size byType (2020-2025) & ($ millions)
Table 37. Europe Biodefense Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Biodefense Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Biodefense Market Size byType (2020-2025) & ($ millions)
Table 40. Middle East & Africa Biodefense Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Biodefense
Table 42. Key Market Challenges & Risks of Biodefense
Table 43. Key IndustryTrends of Biodefense
Table 44. Global Biodefense Market SizeForecast by Region (2026-2031) & ($ millions)
Table 45. Global Biodefense Market Size Market ShareForecast by Region (2026-2031)
Table 46. Global Biodefense Market SizeForecast byType (2026-2031) & ($ millions)
Table 47. Global Biodefense Market SizeForecast by Application (2026-2031) & ($ millions)
Table 48. Emergent Biosolutions Details, CompanyType, Biodefense Area Served and Its Competitors
Table 49. Emergent Biosolutions Biodefense Product Offered
Table 50. Emergent Biosolutions Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Emergent Biosolutions Main Business
Table 52. Emergent Biosolutions Latest Developments
Table 53. Hytest Details, CompanyType, Biodefense Area Served and Its Competitors
Table 54. Hytest Biodefense Product Offered
Table 55. Hytest Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Hytest Main Business
Table 57. Hytest Latest Developments
Table 58. GSK Details, CompanyType, Biodefense Area Served and Its Competitors
Table 59. GSK Biodefense Product Offered
Table 60. GSK Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. GSK Main Business
Table 62. GSK Latest Developments
Table 63. Sanofi Details, CompanyType, Biodefense Area Served and Its Competitors
Table 64. Sanofi Biodefense Product Offered
Table 65. Sanofi Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Sanofi Main Business
Table 67. Sanofi Latest Developments
Table 68. PharmAthene Details, CompanyType, Biodefense Area Served and Its Competitors
Table 69. PharmAthene Biodefense Product Offered
Table 70. PharmAthene Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. PharmAthene Main Business
Table 72. PharmAthene Latest Developments
Table 73. Bavarian Nordic Details, CompanyType, Biodefense Area Served and Its Competitors
Table 74. Bavarian Nordic Biodefense Product Offered
Table 75. Bavarian Nordic Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Bavarian Nordic Main Business
Table 77. Bavarian Nordic Latest Developments
Table 78. SIGATechnologies Details, CompanyType, Biodefense Area Served and Its Competitors
Table 79. SIGATechnologies Biodefense Product Offered
Table 80. SIGATechnologies Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. SIGATechnologies Main Business
Table 82. SIGATechnologies Latest Developments
Table 83. Arbutus Biopharma Details, CompanyType, Biodefense Area Served and Its Competitors
Table 84. Arbutus Biopharma Biodefense Product Offered
Table 85. Arbutus Biopharma Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Arbutus Biopharma Main Business
Table 87. Arbutus Biopharma Latest Developments
Table 88. DynPort Vaccine Details, CompanyType, Biodefense Area Served and Its Competitors
Table 89. DynPort Vaccine Biodefense Product Offered
Table 90. DynPort Vaccine Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. DynPort Vaccine Main Business
Table 92. DynPort Vaccine Latest Developments
Table 93. Xoma Corporation Details, CompanyType, Biodefense Area Served and Its Competitors
Table 94. Xoma Corporation Biodefense Product Offered
Table 95. Xoma Corporation Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Xoma Corporation Main Business
Table 97. Xoma Corporation Latest Developments
Table 98. Ichor Medical Systems Details, CompanyType, Biodefense Area Served and Its Competitors
Table 99. Ichor Medical Systems Biodefense Product Offered
Table 100. Ichor Medical Systems Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Ichor Medical Systems Main Business
Table 102. Ichor Medical Systems Latest Developments
Table 103. Aeolus Pharmaceuticals Details, CompanyType, Biodefense Area Served and Its Competitors
Table 104. Aeolus Pharmaceuticals Biodefense Product Offered
Table 105. Aeolus Pharmaceuticals Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. Aeolus Pharmaceuticals Main Business
Table 107. Aeolus Pharmaceuticals Latest Developments
Table 108. Achaogen Details, CompanyType, Biodefense Area Served and Its Competitors
Table 109. Achaogen Biodefense Product Offered
Table 110. Achaogen Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Achaogen Main Business
Table 112. Achaogen Latest Developments
Table 113. ElusysTherapeutics Details, CompanyType, Biodefense Area Served and Its Competitors
Table 114. ElusysTherapeutics Biodefense Product Offered
Table 115. ElusysTherapeutics Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. ElusysTherapeutics Main Business
Table 117. ElusysTherapeutics Latest Developments
Table 118. DynavaxTechnologies Details, CompanyType, Biodefense Area Served and Its Competitors
Table 119. DynavaxTechnologies Biodefense Product Offered
Table 120. DynavaxTechnologies Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. DynavaxTechnologies Main Business
Table 122. DynavaxTechnologies Latest Developments
Table 123. Cleveland BioLabs Details, CompanyType, Biodefense Area Served and Its Competitors
Table 124. Cleveland BioLabs Biodefense Product Offered
Table 125. Cleveland BioLabs Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. Cleveland BioLabs Main Business
Table 127. Cleveland BioLabs Latest Developments
Table 128. Soligenix Details, CompanyType, Biodefense Area Served and Its Competitors
Table 129. Soligenix Biodefense Product Offered
Table 130. Soligenix Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. Soligenix Main Business
Table 132. Soligenix Latest Developments
Table 133. Alnylam Pharmaceuticals Details, CompanyType, Biodefense Area Served and Its Competitors
Table 134. Alnylam Pharmaceuticals Biodefense Product Offered
Table 135. Alnylam Pharmaceuticals Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136. Alnylam Pharmaceuticals Main Business
Table 137. Alnylam Pharmaceuticals Latest Developments
Table 1. Biodefense Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Biodefense Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Anthrax
Table 4. Major Players of Smallpox
Table 5. Major Players of Botulism
Table 6. Major Players of Radiation/Nuclear
Table 7. Major Players of Others
Table 8. Biodefense Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Biodefense Market Size byType (2020-2025) & ($ millions)
Table 10. Global Biodefense Market Size Market Share byType (2020-2025)
Table 11. Biodefense Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Biodefense Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Biodefense Market Size Market Share by Application (2020-2025)
Table 14. Global Biodefense Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Biodefense Revenue Market Share by Player (2020-2025)
Table 16. Biodefense Key Players Head office and Products Offered
Table 17. Biodefense Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Biodefense Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Biodefense Market Size Market Share by Region (2020-2025)
Table 22. Global Biodefense Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Biodefense Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Biodefense Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Biodefense Market Size Market Share by Country (2020-2025)
Table 26. Americas Biodefense Market Size byType (2020-2025) & ($ millions)
Table 27. Americas Biodefense Market Size Market Share byType (2020-2025)
Table 28. Americas Biodefense Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Biodefense Market Size Market Share by Application (2020-2025)
Table 30. APAC Biodefense Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Biodefense Market Size Market Share by Region (2020-2025)
Table 32. APAC Biodefense Market Size byType (2020-2025) & ($ millions)
Table 33. APAC Biodefense Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Biodefense Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Biodefense Market Size Market Share by Country (2020-2025)
Table 36. Europe Biodefense Market Size byType (2020-2025) & ($ millions)
Table 37. Europe Biodefense Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Biodefense Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Biodefense Market Size byType (2020-2025) & ($ millions)
Table 40. Middle East & Africa Biodefense Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Biodefense
Table 42. Key Market Challenges & Risks of Biodefense
Table 43. Key IndustryTrends of Biodefense
Table 44. Global Biodefense Market SizeForecast by Region (2026-2031) & ($ millions)
Table 45. Global Biodefense Market Size Market ShareForecast by Region (2026-2031)
Table 46. Global Biodefense Market SizeForecast byType (2026-2031) & ($ millions)
Table 47. Global Biodefense Market SizeForecast by Application (2026-2031) & ($ millions)
Table 48. Emergent Biosolutions Details, CompanyType, Biodefense Area Served and Its Competitors
Table 49. Emergent Biosolutions Biodefense Product Offered
Table 50. Emergent Biosolutions Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Emergent Biosolutions Main Business
Table 52. Emergent Biosolutions Latest Developments
Table 53. Hytest Details, CompanyType, Biodefense Area Served and Its Competitors
Table 54. Hytest Biodefense Product Offered
Table 55. Hytest Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Hytest Main Business
Table 57. Hytest Latest Developments
Table 58. GSK Details, CompanyType, Biodefense Area Served and Its Competitors
Table 59. GSK Biodefense Product Offered
Table 60. GSK Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. GSK Main Business
Table 62. GSK Latest Developments
Table 63. Sanofi Details, CompanyType, Biodefense Area Served and Its Competitors
Table 64. Sanofi Biodefense Product Offered
Table 65. Sanofi Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Sanofi Main Business
Table 67. Sanofi Latest Developments
Table 68. PharmAthene Details, CompanyType, Biodefense Area Served and Its Competitors
Table 69. PharmAthene Biodefense Product Offered
Table 70. PharmAthene Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. PharmAthene Main Business
Table 72. PharmAthene Latest Developments
Table 73. Bavarian Nordic Details, CompanyType, Biodefense Area Served and Its Competitors
Table 74. Bavarian Nordic Biodefense Product Offered
Table 75. Bavarian Nordic Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Bavarian Nordic Main Business
Table 77. Bavarian Nordic Latest Developments
Table 78. SIGATechnologies Details, CompanyType, Biodefense Area Served and Its Competitors
Table 79. SIGATechnologies Biodefense Product Offered
Table 80. SIGATechnologies Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. SIGATechnologies Main Business
Table 82. SIGATechnologies Latest Developments
Table 83. Arbutus Biopharma Details, CompanyType, Biodefense Area Served and Its Competitors
Table 84. Arbutus Biopharma Biodefense Product Offered
Table 85. Arbutus Biopharma Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Arbutus Biopharma Main Business
Table 87. Arbutus Biopharma Latest Developments
Table 88. DynPort Vaccine Details, CompanyType, Biodefense Area Served and Its Competitors
Table 89. DynPort Vaccine Biodefense Product Offered
Table 90. DynPort Vaccine Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. DynPort Vaccine Main Business
Table 92. DynPort Vaccine Latest Developments
Table 93. Xoma Corporation Details, CompanyType, Biodefense Area Served and Its Competitors
Table 94. Xoma Corporation Biodefense Product Offered
Table 95. Xoma Corporation Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Xoma Corporation Main Business
Table 97. Xoma Corporation Latest Developments
Table 98. Ichor Medical Systems Details, CompanyType, Biodefense Area Served and Its Competitors
Table 99. Ichor Medical Systems Biodefense Product Offered
Table 100. Ichor Medical Systems Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Ichor Medical Systems Main Business
Table 102. Ichor Medical Systems Latest Developments
Table 103. Aeolus Pharmaceuticals Details, CompanyType, Biodefense Area Served and Its Competitors
Table 104. Aeolus Pharmaceuticals Biodefense Product Offered
Table 105. Aeolus Pharmaceuticals Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. Aeolus Pharmaceuticals Main Business
Table 107. Aeolus Pharmaceuticals Latest Developments
Table 108. Achaogen Details, CompanyType, Biodefense Area Served and Its Competitors
Table 109. Achaogen Biodefense Product Offered
Table 110. Achaogen Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Achaogen Main Business
Table 112. Achaogen Latest Developments
Table 113. ElusysTherapeutics Details, CompanyType, Biodefense Area Served and Its Competitors
Table 114. ElusysTherapeutics Biodefense Product Offered
Table 115. ElusysTherapeutics Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. ElusysTherapeutics Main Business
Table 117. ElusysTherapeutics Latest Developments
Table 118. DynavaxTechnologies Details, CompanyType, Biodefense Area Served and Its Competitors
Table 119. DynavaxTechnologies Biodefense Product Offered
Table 120. DynavaxTechnologies Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. DynavaxTechnologies Main Business
Table 122. DynavaxTechnologies Latest Developments
Table 123. Cleveland BioLabs Details, CompanyType, Biodefense Area Served and Its Competitors
Table 124. Cleveland BioLabs Biodefense Product Offered
Table 125. Cleveland BioLabs Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. Cleveland BioLabs Main Business
Table 127. Cleveland BioLabs Latest Developments
Table 128. Soligenix Details, CompanyType, Biodefense Area Served and Its Competitors
Table 129. Soligenix Biodefense Product Offered
Table 130. Soligenix Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. Soligenix Main Business
Table 132. Soligenix Latest Developments
Table 133. Alnylam Pharmaceuticals Details, CompanyType, Biodefense Area Served and Its Competitors
Table 134. Alnylam Pharmaceuticals Biodefense Product Offered
Table 135. Alnylam Pharmaceuticals Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136. Alnylam Pharmaceuticals Main Business
Table 137. Alnylam Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Biodefense Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biodefense Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Biodefense Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Biodefense Sales Market Share by Country/Region (2024)
Figure 8. Biodefense Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Biodefense Market Size Market Share byType in 2024
Figure 10. Biodefense in US Military Market
Figure 11. Global Biodefense Market: US Military Market (2020-2025) & ($ millions)
Figure 12. Biodefense in US Civilian Market
Figure 13. Global Biodefense Market: US Civilian Market (2020-2025) & ($ millions)
Figure 14. Biodefense in Non - US Market
Figure 15. Global Biodefense Market: Non - US Market (2020-2025) & ($ millions)
Figure 16. Global Biodefense Market Size Market Share by Application in 2024
Figure 17. Global Biodefense Revenue Market Share by Player in 2024
Figure 18. Global Biodefense Market Size Market Share by Region (2020-2025)
Figure 19. Americas Biodefense Market Size 2020-2025 ($ millions)
Figure 20. APAC Biodefense Market Size 2020-2025 ($ millions)
Figure 21. Europe Biodefense Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Biodefense Market Size 2020-2025 ($ millions)
Figure 23. Americas Biodefense Value Market Share by Country in 2024
Figure 24. United States Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Biodefense Market Size Market Share by Region in 2024
Figure 29. APAC Biodefense Market Size Market Share byType (2020-2025)
Figure 30. APAC Biodefense Market Size Market Share by Application (2020-2025)
Figure 31. China Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 35. India Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Biodefense Market Size Market Share by Country in 2024
Figure 38. Europe Biodefense Market Size Market Share byType (2020-2025)
Figure 39. Europe Biodefense Market Size Market Share by Application (2020-2025)
Figure 40. Germany Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 41.France Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Biodefense Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Biodefense Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Biodefense Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Biodefense Market Size 2026-2031 ($ millions)
Figure 54. APAC Biodefense Market Size 2026-2031 ($ millions)
Figure 55. Europe Biodefense Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Biodefense Market Size 2026-2031 ($ millions)
Figure 57. United States Biodefense Market Size 2026-2031 ($ millions)
Figure 58. Canada Biodefense Market Size 2026-2031 ($ millions)
Figure 59. Mexico Biodefense Market Size 2026-2031 ($ millions)
Figure 60. Brazil Biodefense Market Size 2026-2031 ($ millions)
Figure 61. China Biodefense Market Size 2026-2031 ($ millions)
Figure 62. Japan Biodefense Market Size 2026-2031 ($ millions)
Figure 63. Korea Biodefense Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Biodefense Market Size 2026-2031 ($ millions)
Figure 65. India Biodefense Market Size 2026-2031 ($ millions)
Figure 66. Australia Biodefense Market Size 2026-2031 ($ millions)
Figure 67. Germany Biodefense Market Size 2026-2031 ($ millions)
Figure 68.France Biodefense Market Size 2026-2031 ($ millions)
Figure 69. UK Biodefense Market Size 2026-2031 ($ millions)
Figure 70. Italy Biodefense Market Size 2026-2031 ($ millions)
Figure 71. Russia Biodefense Market Size 2026-2031 ($ millions)
Figure 72. Egypt Biodefense Market Size 2026-2031 ($ millions)
Figure 73. South Africa Biodefense Market Size 2026-2031 ($ millions)
Figure 74. Israel Biodefense Market Size 2026-2031 ($ millions)
Figure 75.Turkey Biodefense Market Size 2026-2031 ($ millions)
Figure 76. Global Biodefense Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Biodefense Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Biodefense Market Size 2026-2031 ($ millions)
Figure 1. Biodefense Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biodefense Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Biodefense Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Biodefense Sales Market Share by Country/Region (2024)
Figure 8. Biodefense Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Biodefense Market Size Market Share byType in 2024
Figure 10. Biodefense in US Military Market
Figure 11. Global Biodefense Market: US Military Market (2020-2025) & ($ millions)
Figure 12. Biodefense in US Civilian Market
Figure 13. Global Biodefense Market: US Civilian Market (2020-2025) & ($ millions)
Figure 14. Biodefense in Non - US Market
Figure 15. Global Biodefense Market: Non - US Market (2020-2025) & ($ millions)
Figure 16. Global Biodefense Market Size Market Share by Application in 2024
Figure 17. Global Biodefense Revenue Market Share by Player in 2024
Figure 18. Global Biodefense Market Size Market Share by Region (2020-2025)
Figure 19. Americas Biodefense Market Size 2020-2025 ($ millions)
Figure 20. APAC Biodefense Market Size 2020-2025 ($ millions)
Figure 21. Europe Biodefense Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Biodefense Market Size 2020-2025 ($ millions)
Figure 23. Americas Biodefense Value Market Share by Country in 2024
Figure 24. United States Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Biodefense Market Size Market Share by Region in 2024
Figure 29. APAC Biodefense Market Size Market Share byType (2020-2025)
Figure 30. APAC Biodefense Market Size Market Share by Application (2020-2025)
Figure 31. China Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 35. India Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Biodefense Market Size Market Share by Country in 2024
Figure 38. Europe Biodefense Market Size Market Share byType (2020-2025)
Figure 39. Europe Biodefense Market Size Market Share by Application (2020-2025)
Figure 40. Germany Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 41.France Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Biodefense Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Biodefense Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Biodefense Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Biodefense Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Biodefense Market Size 2026-2031 ($ millions)
Figure 54. APAC Biodefense Market Size 2026-2031 ($ millions)
Figure 55. Europe Biodefense Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Biodefense Market Size 2026-2031 ($ millions)
Figure 57. United States Biodefense Market Size 2026-2031 ($ millions)
Figure 58. Canada Biodefense Market Size 2026-2031 ($ millions)
Figure 59. Mexico Biodefense Market Size 2026-2031 ($ millions)
Figure 60. Brazil Biodefense Market Size 2026-2031 ($ millions)
Figure 61. China Biodefense Market Size 2026-2031 ($ millions)
Figure 62. Japan Biodefense Market Size 2026-2031 ($ millions)
Figure 63. Korea Biodefense Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Biodefense Market Size 2026-2031 ($ millions)
Figure 65. India Biodefense Market Size 2026-2031 ($ millions)
Figure 66. Australia Biodefense Market Size 2026-2031 ($ millions)
Figure 67. Germany Biodefense Market Size 2026-2031 ($ millions)
Figure 68.France Biodefense Market Size 2026-2031 ($ millions)
Figure 69. UK Biodefense Market Size 2026-2031 ($ millions)
Figure 70. Italy Biodefense Market Size 2026-2031 ($ millions)
Figure 71. Russia Biodefense Market Size 2026-2031 ($ millions)
Figure 72. Egypt Biodefense Market Size 2026-2031 ($ millions)
Figure 73. South Africa Biodefense Market Size 2026-2031 ($ millions)
Figure 74. Israel Biodefense Market Size 2026-2031 ($ millions)
Figure 75.Turkey Biodefense Market Size 2026-2031 ($ millions)
Figure 76. Global Biodefense Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Biodefense Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Biodefense Market Size 2026-2031 ($ millions)
More Publications
Global Traditional Food Steamer Market Growth 2025-2031
US$ 3,660.00
October 2025
125 pages
Global Luxury Hats Market Growth 2025-2031
US$ 3,660.00
October 2025
144 pages
Global Speed Bags Market Growth 2025-2031
US$ 3,660.00
October 2025
93 pages
Global Nail Clipper Set Market Growth 2024-2030
US$ 3,660.00
March 2024
138 pages
